ARK Genomic Revolution ETF vs Workiva Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Workiva Inc trades at $68.9 (market cap $3.76B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | WK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $93.31 |
52-Week Low | $24.02 | $44.31 |
Market Cap | — | $3.76B |
Enterprise Value | — | $3.73B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →